Global Castrate-resistant Prostate Cancer Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Castrate-resistant Prostate Cancer Treatment Market Size 2017-2028

2.1.2 Castrate-resistant Prostate Cancer Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Castrate-resistant Prostate Cancer Treatment Segment by Type

2.2.1 Chemotherapy

2.2.2 Hormonal Therapy

2.2.3 Immunotherapy

2.2.4 Radiotherapy

2.3 Castrate-resistant Prostate Cancer Treatment Market Size by Type

2.3.1 Castrate-resistant Prostate Cancer Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2022)

2.4 Castrate-resistant Prostate Cancer Treatment Segment by Application

2.4.1 Hospital

2.4.2 Clinics

2.4.3 Others

2.5 Castrate-resistant Prostate Cancer Treatment Market Size by Application

2.5.1 Castrate-resistant Prostate Cancer Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2022)

3 Castrate-resistant Prostate Cancer Treatment Market Size by Player

3.1 Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Players

3.1.1 Global Castrate-resistant Prostate Cancer Treatment Revenue by Players (2020-2022)

3.1.2 Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Castrate-resistant Prostate Cancer Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Castrate-resistant Prostate Cancer Treatment by Regions

4.1 Castrate-resistant Prostate Cancer Treatment Market Size by Regions (2017-2022)

4.2 Americas Castrate-resistant Prostate Cancer Treatment Market Size Growth (2017-2022)

4.3 APAC Castrate-resistant Prostate Cancer Treatment Market Size Growth (2017-2022)

4.4 Europe Castrate-resistant Prostate Cancer Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Castrate-resistant Prostate Cancer Treatment Market Size by Country (2017-2022)

5.2 Americas Castrate-resistant Prostate Cancer Treatment Market Size by Type (2017-2022)

5.3 Americas Castrate-resistant Prostate Cancer Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Castrate-resistant Prostate Cancer Treatment Market Size by Region (2017-2022)

6.2 APAC Castrate-resistant Prostate Cancer Treatment Market Size by Type (2017-2022)

6.3 APAC Castrate-resistant Prostate Cancer Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Castrate-resistant Prostate Cancer Treatment by Country (2017-2022)

7.2 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Type (2017-2022)

7.3 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Castrate-resistant Prostate Cancer Treatment by Region (2017-2022)

8.2 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Castrate-resistant Prostate Cancer Treatment Market Forecast

10.1 Global Castrate-resistant Prostate Cancer Treatment Forecast by Regions (2023-2028)

10.1.1 Global Castrate-resistant Prostate Cancer Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Castrate-resistant Prostate Cancer Treatment Forecast

10.1.3 APAC Castrate-resistant Prostate Cancer Treatment Forecast

10.1.4 Europe Castrate-resistant Prostate Cancer Treatment Forecast

10.1.5 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Forecast

10.2 Americas Castrate-resistant Prostate Cancer Treatment Forecast by Country (2023-2028)

10.2.1 United States Castrate-resistant Prostate Cancer Treatment Market Forecast

10.2.2 Canada Castrate-resistant Prostate Cancer Treatment Market Forecast

10.2.3 Mexico Castrate-resistant Prostate Cancer Treatment Market Forecast

10.2.4 Brazil Castrate-resistant Prostate Cancer Treatment Market Forecast

10.3 APAC Castrate-resistant Prostate Cancer Treatment Forecast by Region (2023-2028)

10.3.1 China Castrate-resistant Prostate Cancer Treatment Market Forecast

10.3.2 Japan Castrate-resistant Prostate Cancer Treatment Market Forecast

10.3.3 Korea Castrate-resistant Prostate Cancer Treatment Market Forecast

10.3.4 Southeast Asia Castrate-resistant Prostate Cancer Treatment Market Forecast

10.3.5 India Castrate-resistant Prostate Cancer Treatment Market Forecast

10.3.6 Australia Castrate-resistant Prostate Cancer Treatment Market Forecast

10.4 Europe Castrate-resistant Prostate Cancer Treatment Forecast by Country (2023-2028)

10.4.1 Germany Castrate-resistant Prostate Cancer Treatment Market Forecast

10.4.2 France Castrate-resistant Prostate Cancer Treatment Market Forecast

10.4.3 UK Castrate-resistant Prostate Cancer Treatment Market Forecast

10.4.4 Italy Castrate-resistant Prostate Cancer Treatment Market Forecast

10.4.5 Russia Castrate-resistant Prostate Cancer Treatment Market Forecast

10.5 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Castrate-resistant Prostate Cancer Treatment Market Forecast

10.5.2 South Africa Castrate-resistant Prostate Cancer Treatment Market Forecast

10.5.3 Israel Castrate-resistant Prostate Cancer Treatment Market Forecast

10.5.4 Turkey Castrate-resistant Prostate Cancer Treatment Market Forecast

10.5.5 GCC Countries Castrate-resistant Prostate Cancer Treatment Market Forecast

10.6 Global Castrate-resistant Prostate Cancer Treatment Forecast by Type (2023-2028)

10.7 Global Castrate-resistant Prostate Cancer Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Sanofi

11.1.1 Sanofi Company Information

11.1.2 Sanofi Castrate-resistant Prostate Cancer Treatment Product Offered

11.1.3 Sanofi Castrate-resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Sanofi Main Business Overview

11.1.5 Sanofi Latest Developments

11.2 Johnson & Johnson Services, Inc.

11.2.1 Johnson & Johnson Services, Inc. Company Information

11.2.2 Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Product Offered

11.2.3 Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Johnson & Johnson Services, Inc. Main Business Overview

11.2.5 Johnson & Johnson Services, Inc. Latest Developments

11.3 Pfizer, Inc.

11.3.1 Pfizer, Inc. Company Information

11.3.2 Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Product Offered

11.3.3 Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Pfizer, Inc. Main Business Overview

11.3.5 Pfizer, Inc. Latest Developments

11.4 Astellas Pharma, Inc.

11.4.1 Astellas Pharma, Inc. Company Information

11.4.2 Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Product Offered

11.4.3 Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Astellas Pharma, Inc. Main Business Overview

11.4.5 Astellas Pharma, Inc. Latest Developments

11.5 Bayer AG

11.5.1 Bayer AG Company Information

11.5.2 Bayer AG Castrate-resistant Prostate Cancer Treatment Product Offered

11.5.3 Bayer AG Castrate-resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Bayer AG Main Business Overview

11.5.5 Bayer AG Latest Developments

12 Research Findings and Conclusion

Table 1. Castrate-resistant Prostate Cancer Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Chemotherapy

Table 3. Major Players of Hormonal Therapy

Table 4. Major Players of Immunotherapy

Table 5. Major Players of Radiotherapy

Table 6. Castrate-resistant Prostate Cancer Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Castrate-resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2022)

Table 9. Castrate-resistant Prostate Cancer Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Castrate-resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2022)

Table 12. Global Castrate-resistant Prostate Cancer Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Player (2020-2022)

Table 14. Castrate-resistant Prostate Cancer Treatment Key Players Head office and Products Offered

Table 15. Castrate-resistant Prostate Cancer Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Castrate-resistant Prostate Cancer Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Regions (2017-2022)

Table 20. Americas Castrate-resistant Prostate Cancer Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Country (2017-2022)

Table 22. Americas Castrate-resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2022)

Table 24. Americas Castrate-resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2022)

Table 26. APAC Castrate-resistant Prostate Cancer Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Region (2017-2022)

Table 28. APAC Castrate-resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2022)

Table 30. APAC Castrate-resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2022)

Table 32. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Country (2017-2022)

Table 34. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2022)

Table 36. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Castrate-resistant Prostate Cancer Treatment

Table 45. Key Market Challenges & Risks of Castrate-resistant Prostate Cancer Treatment

Table 46. Key Industry Trends of Castrate-resistant Prostate Cancer Treatment

Table 47. Global Castrate-resistant Prostate Cancer Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Castrate-resistant Prostate Cancer Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Castrate-resistant Prostate Cancer Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 53. Sanofi Details, Company Type, Castrate-resistant Prostate Cancer Treatment Area Served and Its Competitors

Table 54. Sanofi Castrate-resistant Prostate Cancer Treatment Product Offered

Table 55. Sanofi Castrate-resistant Prostate Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Sanofi Main Business

Table 57. Sanofi Latest Developments

Table 58. Johnson & Johnson Services, Inc. Details, Company Type, Castrate-resistant Prostate Cancer Treatment Area Served and Its Competitors

Table 59. Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Product Offered

Table 60. Johnson & Johnson Services, Inc. Main Business

Table 61. Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Johnson & Johnson Services, Inc. Latest Developments

Table 63. Pfizer, Inc. Details, Company Type, Castrate-resistant Prostate Cancer Treatment Area Served and Its Competitors

Table 64. Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Product Offered

Table 65. Pfizer, Inc. Main Business

Table 66. Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Pfizer, Inc. Latest Developments

Table 68. Astellas Pharma, Inc. Details, Company Type, Castrate-resistant Prostate Cancer Treatment Area Served and Its Competitors

Table 69. Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Product Offered

Table 70. Astellas Pharma, Inc. Main Business

Table 71. Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Astellas Pharma, Inc. Latest Developments

Table 73. Bayer AG Details, Company Type, Castrate-resistant Prostate Cancer Treatment Area Served and Its Competitors

Table 74. Bayer AG Castrate-resistant Prostate Cancer Treatment Product Offered

Table 75. Bayer AG Main Business

Table 76. Bayer AG Castrate-resistant Prostate Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Bayer AG Latest Developments

List of Figures

Figure 1. Castrate-resistant Prostate Cancer Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Type in 2021

Figure 7. Castrate-resistant Prostate Cancer Treatment in Hospital

Figure 8. Global Castrate-resistant Prostate Cancer Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Castrate-resistant Prostate Cancer Treatment in Clinics

Figure 10. Global Castrate-resistant Prostate Cancer Treatment Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Castrate-resistant Prostate Cancer Treatment in Others

Figure 12. Global Castrate-resistant Prostate Cancer Treatment Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application in 2021

Figure 14. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Player in 2021

Figure 15. Global Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Castrate-resistant Prostate Cancer Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Castrate-resistant Prostate Cancer Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Castrate-resistant Prostate Cancer Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Castrate-resistant Prostate Cancer Treatment Value Market Share by Country in 2021

Figure 21. Americas Castrate-resistant Prostate Cancer Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application in 2021

Figure 23. United States Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application in 2021

Figure 29. China Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Castrate-resistant Prostate Cancer Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Castrate-resistant Prostate Cancer Treatment Market Size 2023-2028 ($ Millions)